Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC2134 flu-dnb

Novel photolabile NO donor

1160555-05-4
DCC2135 Flufenacet

Herbicide, inhibiting very-long-chain fatty acid elongase (VLCFAE) synthesis

142459-58-3
DCC2136 Fluo-3

Green-fluorescent intracellular calcium indicator

121714-13-4
DCC2137 Fluo-3 Am

Green-fluorescent intracellular calcium indicator

121714-22-5
DCC2138 Fluoroclorgyline

Monoamine oxidase A (MAO-A) specific inhibitor

135062-18-9
DCC2139 Fluoroethylnormemantine

Novel potent neuroprotective agent for treatment of Alzheimer's disease (AD), targeting NMDA receptor

1639210-26-6
DCC2140 Fluoroethylnormemantine Hcl

Novel potent neuroprotective agent for treatment of Alzheimer's disease (AD), targeting NMDA receptor

1639210-25-5
DCC2141 fluoxatrobin

Fungicide for the control of fungal diseases such as early blight, late blight, leaf spots, leaf rust, and Rhizoctonia solani.

361377-29-9
DCC2142 Fluperlapine

Atypical antipsychotic agent and ligand for the serotonin receptors 5-HT6/5-HT7

67121-76-0
DCC2143 Fluphenazine Decanoate

Antipsychotic agent, blocking postsynaptic dopamine D2 receptors in the limbic, cortical system and basal ganglia

5002-47-1
DCC2144 Fluphenazine Decanoate Dihydrochloride

Antipsychotic agent, blocking postsynaptic dopamine D2 receptors in the limbic, cortical system and basal ganglia

2376-65-0
DCC2145 Flutazolam

Benzodiazepine with sedative, muscle relaxant, anticonvulsant, and anxiolytic activities

27060-91-9
DCC2146 Flutonidine

alpha2-Adrenergic receptor agonist

28125-87-3
DCC2147 Fm4-64

Fluorescent probe for monitoring synaptic activity at neuromuscular junctions

162112-35-8
DCC2148 Fm-476

Negative control for FM-381

DCC2149 Fm-743

Negative control for Skepinone-L

DCC2150 Fmf-01-086-2

Novel highly selective inhibitor of Aurora kinases A, B and C, with potent cellular activity and minimal off-target activity (PLK4)

2135622-31-8
DCC2151 Fmf-02-063-1

Novel potent and selective Dual inhibitor of PI3K-δ and PI3K-γ

DCC2152 Fmf-04-159-r

Novel potent dual CDK14 and CDK16 inhibitor

DCC2153 Fmp-401319-3

Novel concentration-dependent inhibitor of CRF1R-pPL cotranslational translocation at the level of the Sec61 complex

438212-56-7
DCC2154 Fnd-4b

Novel AMPK activator, inhibiting growth and induces apoptosis in colon cancer and increasing apoptosis in triple negative and estrogen-receptor positive breast cancers

DCC2155 Fndr-20081

First in class anti-tubercular agent against sensitive and drug-resistant Mycobacterium tuberculosis (Mtb)

Page 1319 / Total 1557 FirstPrevNextLastGoto